Ocular Ischemic Diseases: From Molecular Mechanisms to Therapeutics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 213
Special Issue Editor
Interests: neuroprotection; ischemia; hypoxia; neovascularization; macular degeneration; stroke; glucose and lipid metabolism; oxidative stress; anti-aging; nicotinamide adenine dinucleotide; vitamin supplements; hypoxia-inducible factors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ocular ischemia is one of the leading causes of visual loss. Many eye diseases, including diabetic retinopathy, retinopathy of prematurity, retinal vein/artery occlusion, pathologic myopia, age-related macular degeneration, glaucoma, and ocular ischemic syndrome, are highly related to ocular ischemia. To develop or find promising preventive or protective drugs in ocular ischemic diseases, the complex molecular mechanisms of pathologies in ocular ischemia need to first be well understood.
This Special Issue aims to collect original research and review articles that summarize recent state-of-the-art findings, focusing on unravelling the pathologic molecular pathways in various types of ocular ischemic diseases and suggesting novel therapeutic molecular targets in terms of the prevention and treatment of ocular ischemia.
Topics include, but are not limited to, the following:
- Diabetic retinopathy.
- Retinopathy of prematurity.
- Retinal vein occlusion.
- Retinal artery occlusion.
- Pathologic myopia.
- Age-related macular degeneration.
- Glaucoma.
- Ocular ischemic syndrome.
Dr. Deokho Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetic retinopathy
- retinopathy of prematurity
- retinal vein occlusion
- retinal artery occlusion
- pathologic myopia
- age-related macular degeneration
- glaucoma
- ocular ischemic syndrome
